Kirsten E, Jackowski G, McLick J, Hakam A, Decker K, Kun E
Exp Cell Res. 1985 Nov;161(1):41-52. doi: 10.1016/0014-4827(85)90488-4.
The in vitro rates (vinit) of poly(ADP-ribose) polymerase of permeabilized rat hepatocytes and of nuclei, isolated from hepatocytes, did not differ significantly. Incubation beyond 3 min resulted in diminished poly(ADP) ribosylation in hepatocytes compared with nuclei, coinciding with high rates of plasma membrane-associated NAD-glycohydrolase. Cultured cells (Drosophila Kc cells, gliosarcoma 9L, human fibroblasts and mouse spleen lymphocytes) exhibit variations of NAD-glycohydrolase and poly(ADP-ribose) polymerase activities and the assessment of poly(ADP-ribose) polymerase activity in permeabilized cells requires simultaneous assay of NAD-glycohydrolase. In rat liver nuclei during 10 min incubation with 500 microM NAD, 40% of NAD is consumed, 10% ADP-ribose is bound to proteins, and 20% ADP-ribose, 5% AMP and 2.7% adenosine are liberated. As determined by solvent partitioning (Jackowski, G & Kun, E, J biol chem 258 (1983) 12587) [1], the phenol-soluble protein-ADP-ribose fraction represents largely mono(ADP)-ribose protein adducts, whereas the H2O-soluble phase contains poly(ADP)-ribosylated proteins. The quantity of ADP-ribose protein adducts, the chain length of oligomers and the nature of apparent acceptor proteins in liver nuclei vary significantly with the concentration of NAD as substrate. At 500 microM NAD concentration the quantity of ADP-ribose containing adducts was in the nmol per mg DNA range, the polymers are long chains and the acceptor proteins predominantly non-histone proteins. At 0.1 microM NAD as substrate pmol quantities of monomeric ADP-ribose adducts per mg DNA were formed and the main acceptors were sharply discernable on the basis of molecular mass as histones, high mobility non-histone proteins, two protein groups of a mass of 66 and 44 kD respectively, and the poly(ADP-ribose) polymerase enzyme protein of 119 kD mass. Whereas products in the presence of 0.1 microM NAD may indicate acceptors of highest reactivity, protein adducts formed in the presence of 500 microM NAD resemble a pattern found in vivo.
通透化大鼠肝细胞以及从肝细胞分离得到的细胞核中,聚(ADP - 核糖)聚合酶的体外速率(vinit)并无显著差异。与细胞核相比,肝细胞孵育超过3分钟会导致聚(ADP)核糖基化减少,这与质膜相关的NAD - 糖水解酶的高活性相吻合。培养细胞(果蝇Kc细胞、胶质肉瘤9L细胞、人成纤维细胞和小鼠脾淋巴细胞)表现出NAD - 糖水解酶和聚(ADP - 核糖)聚合酶活性的变化,并且在通透化细胞中评估聚(ADP - 核糖)聚合酶活性需要同时检测NAD - 糖水解酶。在大鼠肝细胞核中,与500μM NAD孵育10分钟期间,40%的NAD被消耗,10%的ADP - 核糖与蛋白质结合,20%的ADP - 核糖、5%的AMP和2.7%的腺苷被释放。通过溶剂分配法(Jackowski, G & Kun, E, J biol chem 258 (1983) 12587)[1]测定,酚溶性蛋白 - ADP - 核糖部分主要代表单(ADP) - 核糖蛋白加合物,而水溶性部分则含有聚(ADP) - 核糖基化蛋白。肝细胞核中ADP - 核糖蛋白加合物的数量、寡聚物的链长以及表观受体蛋白的性质会随作为底物的NAD浓度而显著变化。在500μM NAD浓度下,含ADP - 核糖加合物的数量处于每毫克DNA纳摩尔范围内,聚合物为长链,受体蛋白主要是非组蛋白。以0.1μM NAD作为底物时,每毫克DNA形成皮摩尔量的单体ADP - 核糖加合物,主要受体根据分子量可清晰辨别为组蛋白、高迁移率非组蛋白、分别为66和44 kD的两个蛋白组以及质量为119 kD的聚(ADP - 核糖)聚合酶酶蛋白。虽然在0.1μM NAD存在下的产物可能表明具有最高反应活性的受体,但在500μM NAD存在下形成的蛋白加合物类似于在体内发现的模式。